89 related articles for article (PubMed ID: 3833355)
1. [Influence of isosorbide-5-mononitrate on the tolerance test to exertion in angina pectoris].
Cherchi A; Lai C; Onnis E; Cherchi A; Meloni L; Pirisi R
Cardiologia; 1985 Jun; 30(6):439-48. PubMed ID: 3833355
[No Abstract] [Full Text] [Related]
2. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
3. [Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
Martín Luengo C; Nieto Ballesteros F; Santos Rodríguez I; Diego Domínguez M; Fernández Esteban T; Avila Escribano C; Pavón Osuna P; Cascón Bueno M
An Med Interna; 1990 Jan; 7(1):24-7. PubMed ID: 2103193
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
Brunner D; Meshulam N; Weisbort J
Int J Cardiol; 1987 Sep; 16(3):303-7. PubMed ID: 3654028
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
6. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
Yasky J; Ontanilla E; Koch JE
Cardiology; 1991; 79 Suppl 2():27-30. PubMed ID: 1760826
[TBL] [Abstract][Full Text] [Related]
7. [Ergometric evaluation of slow-release isosorbide-5-mononitrate in exertional angina with stable threshold].
Fazzini PF; Pucci P
Cardiologia; 1987 Nov; 32(11):1297-302. PubMed ID: 3447703
[No Abstract] [Full Text] [Related]
8. Is isosorbide mononitrate better than the dinitrate?
Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
[No Abstract] [Full Text] [Related]
9. [Paired bicycle exercise test in assessment of clinical efficacy of isosorbide-5-mononitrate in patients with stable angina of effort].
Belenkov IuN; Ageev FT; Nuraliev EIu; Prostakova TS; Dzhakhangirov TSh
Kardiologiia; 2005; 45(9):11-5. PubMed ID: 16234785
[No Abstract] [Full Text] [Related]
10. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
[No Abstract] [Full Text] [Related]
11. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
[TBL] [Abstract][Full Text] [Related]
12. [The effect of isosorbide nitrate, isosorbide-2- and 5-mononitrate on the exertion ECG and on the hemodynamics during atrial stimulation in patients with angina pectoris].
Stauch M; Grewe N
Z Kardiol; 1979 Oct; 68(10):687-93. PubMed ID: 516844
[No Abstract] [Full Text] [Related]
13. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
[No Abstract] [Full Text] [Related]
14. [Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
Erlemeier HH; Kupper W; Lange S; Bleifeld W
Z Kardiol; 1986; 75 Suppl 3():112-4. PubMed ID: 3541415
[TBL] [Abstract][Full Text] [Related]
15. Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
Ganzinger U
Arzneimittelforschung; 1992 Mar; 42(3):307-10. PubMed ID: 1497689
[TBL] [Abstract][Full Text] [Related]
16. The effect of pindolol and isosorbide dinitrate and their combination on exercise tolerance and ECG changes in angina pectoris.
Storstein L
Acta Med Scand; 1981; 209(5):357-62. PubMed ID: 7018179
[TBL] [Abstract][Full Text] [Related]
17. Nitrate tolerance.
Parker JO
Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
[TBL] [Abstract][Full Text] [Related]
18. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
19. Extended-release isosorbide mononitrate for angina.
Med Lett Drugs Ther; 1994 Feb; 36(915):13-4. PubMed ID: 8283957
[No Abstract] [Full Text] [Related]
20. An evaluation of the effects of isosorbide 5-mononitrate in patients with angina on effort using dynamic electrocardiography and echocardiography.
Novo S; Nardi E; Alaimo G; Centineo G; Licata G; Strano A
Cardiology; 1987; 74 Suppl 1():20-8. PubMed ID: 3300974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]